Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The spliceosome is a therapeutic vulnerability in MYC-driven cancer
Tiffany Hsu, Lukas M. Simon, Nicholas J. Neill, et al.
Nature (2015) Vol. 525, Iss. 7569, pp. 384-388
Open Access | Times Cited: 468

Showing 1-25 of 468 citing articles:

RNA mis-splicing in disease
Marina M. Scotti, Maurice S. Swanson
Nature Reviews Genetics (2015) Vol. 17, Iss. 1, pp. 19-32
Open Access | Times Cited: 1048
RNA splicing factors as oncoproteins and tumour suppressors
Heidi Dvinge, Eun Hee Kim, Omar Abdel‐Wahab, et al.
Nature reviews. Cancer (2016) Vol. 16, Iss. 7, pp. 413-430
Open Access | Times Cited: 604
Roles and mechanisms of alternative splicing in cancer — implications for care
Sophie Bonnal, Irene López‐Oreja, Juan Valcárcel
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 8, pp. 457-474
Closed Access | Times Cited: 565
The regulation, functions and clinical relevance of arginine methylation
Ernesto Guccione, Stéphane Richard
Nature Reviews Molecular Cell Biology (2019) Vol. 20, Iss. 10, pp. 642-657
Closed Access | Times Cited: 506
Therapeutic targeting of splicing in cancer
Stanley Chun-Wei Lee, Omar Abdel‐Wahab
Nature Medicine (2016) Vol. 22, Iss. 9, pp. 976-986
Open Access | Times Cited: 503
MYC: connecting selective transcriptional control to global RNA production
Theresia R. Kress, Arianna Sabò, Bruno Amati
Nature reviews. Cancer (2015) Vol. 15, Iss. 10, pp. 593-607
Closed Access | Times Cited: 461
Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance
Richard Marcotte, Azin Sayad, Kevin R. Brown, et al.
Cell (2016) Vol. 164, Iss. 1-2, pp. 293-309
Open Access | Times Cited: 453
Alternative‐splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics
Laura M. Urbanski, Nathan K. Leclair, Olga Anczuków
Wiley Interdisciplinary Reviews - RNA (2018) Vol. 9, Iss. 4
Open Access | Times Cited: 328
Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing
Fei Teng, Yiwen Chen, Tengfei Xiao, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 26
Open Access | Times Cited: 314
Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis
Yacine Barèche, David Venet, Michail Ignatiadis, et al.
Annals of Oncology (2018) Vol. 29, Iss. 4, pp. 895-902
Open Access | Times Cited: 304
Protein arginine methylation: from enigmatic functions to therapeutic targeting
Qin Wu, Matthieu Schapira, C.H. Arrowsmith, et al.
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 7, pp. 509-530
Closed Access | Times Cited: 300
Lessons from non-canonical splicing
Christopher R. Sibley, Lorea Blázquez, Jernej Ule
Nature Reviews Genetics (2016) Vol. 17, Iss. 7, pp. 407-421
Open Access | Times Cited: 286
Aberrant RNA Splicing in Cancer
Luisa F. Escobar‐Hoyos, Katherine Knorr, Omar Abdel‐Wahab
Annual Review of Cancer Biology (2018) Vol. 3, Iss. 1, pp. 167-185
Open Access | Times Cited: 284
Intron retention as a component of regulated gene expression programs
Aishwarya G. Jacob, Christopher W. J. Smith
Human Genetics (2017) Vol. 136, Iss. 9, pp. 1043-1057
Open Access | Times Cited: 279
Therapeutic targeting of “undruggable” MYC
Víctor Llombart, Marc R. Mansour
EBioMedicine (2021) Vol. 75, pp. 103756-103756
Open Access | Times Cited: 266
RNA splicing dysregulation and the hallmarks of cancer
Robert K. Bradley, Olga Anczuków
Nature reviews. Cancer (2023) Vol. 23, Iss. 3, pp. 135-155
Open Access | Times Cited: 259
Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss
Andrew Fedoriw, Satyajit Rajapurkar, Shane W. O’Brien, et al.
Cancer Cell (2019) Vol. 36, Iss. 1, pp. 100-114.e25
Open Access | Times Cited: 258
Splicing-factor alterations in cancers
Olga Anczuków, Adrian R. Krainer
RNA (2016) Vol. 22, Iss. 9, pp. 1285-1301
Open Access | Times Cited: 256
Target gene-independent functions of MYC oncoproteins
Apoorva Baluapuri, Elmar Wolf, Martin Eilers
Nature Reviews Molecular Cell Biology (2020) Vol. 21, Iss. 5, pp. 255-267
Open Access | Times Cited: 253
The Spliceosome: The Ultimate RNA Chaperone and Sculptor
Panagiotis Papasaikas, Juan Valcárcel
Trends in Biochemical Sciences (2015) Vol. 41, Iss. 1, pp. 33-45
Open Access | Times Cited: 252
Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation
Jia Yi Fong, Luca Pignata, Pierre-Alexis Goy, et al.
Cancer Cell (2019) Vol. 36, Iss. 2, pp. 194-209.e9
Open Access | Times Cited: 236
Uveal melanoma: Towards a molecular understanding
Kyra N. Smit, Martine J. Jager, Annelies de Klein, et al.
Progress in Retinal and Eye Research (2019) Vol. 75, pp. 100800-100800
Open Access | Times Cited: 217
Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells
Sheela A. Abraham, Lisa Hopcroft, Emma Carrick, et al.
Nature (2016) Vol. 534, Iss. 7607, pp. 341-346
Open Access | Times Cited: 205
Defective control of pre–messenger RNA splicing in human disease
Benoı̂t Chabot, Lulzim Shkreta
The Journal of Cell Biology (2016) Vol. 212, Iss. 1, pp. 13-27
Open Access | Times Cited: 203
The role of alternative splicing in cancer: From oncogenesis to drug resistance
Rocco Sciarrillo, Anna Wojtuszkiewicz, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100728-100728
Open Access | Times Cited: 197
Page 1 - Next Page

Scroll to top